Item 5. Market for Registrant’s Common Equity
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity
Securities.
Market Information and Holders
Our common stock is quoted on the OTCID Basic
Market under the symbol “EDGM.” As of April 10, 2026, the last reported sale price of our common stock as reported by the
OTC Markets was $.0055 per share. Any over the counter market quotation reflects inter-dealer prices, without retail mark-up, mark-down
or commission and may not necessarily represent actual transactions. As of December 31, 2025, there were approximately 198 shareholders
of record. This number does not include beneficial owners whose shares are held in the names of various securities brokers, dealers and
registered clearing agencies.
The following table sets forth for the periods
indicated, high and low sales prices of the Company’s common stock as reported by the OTCID Basic Market.
Fiscal Year Ended December 31, 2025
High Price
Low Price
Fourth Quarter
$0.0690
$0.0131
Third Quarter
$0.11
$0.0030
Second Quarter
$0.1
$0.0021
First Quarter
$0.007
$0.0022
Fiscal Year Ended December 31, 2024
High Price
Low Price
Fourth Quarter
$0.01
$0.0006
Third Quarter
$0.01
$0.0016
Second Quarter
$0.0067
$0.0002
First Quarter
$0.0075
$0.0021
Dividends
The Company has not paid dividends on its common
stock to date and does not intend to pay cash dividends in the foreseeable future. The payment of cash dividends in the future will be
dependent upon the terms of agreements restricting our ability to pay dividends, revenues and earnings, if any, capital requirements and
general financial condition and the discretion of the Company’s Board of Directors. It is the present intention of the Company’s
Board of Directors to retain all earnings, if any, for use in the Company’s business operations and, accordingly, the Board of Directors
does not anticipate declaring any dividends in the foreseeable future.
8
Recent Sales of Unregistered Securities
In addition to the equity securities sold by the
Company that were previously reported in a Quarterly Report on Form 10-Q or a Current Report on Form 8-K filed by the Company, the following
sales of equity securities during the period covered by this Report that were not registered under the Securities Act are disclosed below:
On October 7, 2025, the Company issued 6,666,667
shares of restricted common stock to an accredited investor pursuant to a subscription agreement between the Company and the investor
dated October 7, 2025. The 6,666,667 shares of restricted common stock were issued pursuant to an exemption from registration under
Section 4(a)(2) of the Securities Act.
In October 2025, the Company issued an aggregate
of 16,826,087 shares of common stock upon the cashless exercise of a warrant, which had an exercise price of $0.01 per share and was originally
issued on September 17, 2021. The shares were issued in reliance upon an exemption from registration provided by Section 3(a)(9) of the
Securities Act.
On November 4, 2025, the Company issued 1,833,333
shares of restricted common stock to a service provider pursuant to a services agreement between the Company and the services provider
dated October 31, 2025. The 1,833,333 shares of restricted common stock were issued pursuant to an exemption from registration under
Section 4(a)(2) of the Securities Act.
On November 26, 2025, the Company entered into
a securities purchase agreement with an accredited investor dated November 18, 2025. Pursuant to the securities purchase agreement, the
Company sold to the accredited investor a convertible promissory note in the principal amount of $143,750 for which the Company received
net proceeds of $125,000. The Company also issued to the accredited investor 1,250,000 shares of the Company’s common stock as commitment
shares. The unsecured original issue discount promissory note and shares were issued in a private placement in reliance upon an exemption
from registration provided by Section 4(a)(2) of the Securities Act.
In November 2025, the Company issued an aggregate
of 96,332,497 shares of common stock upon the cashless exercise of a warrant, which had an exercise price of $0.01 per share and was originally
issued on September 17, 2021. The shares were issued in reliance upon an exemption from registration provided by Section 3(a)(9) of the
Securities Act.
In December 2025, the Company issued an aggregate
of 7,892,519 shares of common stock upon the cashless exercise of a warrant, which had an exercise price of $0.01 per share and was originally
issued on September 17, 2021. The shares were issued in reliance upon an exemption from registration provided by Section 3(a)(9) of the
Securities Act.
Under the terms of the respective employment agreements
of Charles Faulkner and Simon Wajcenberg, Mr. Faulkner and Mr. Wajcenberg each had accrued salaries of $386,000 as of October 31, 2025
(each an “Accrued Salary”). On December 10, 2025, in full satisfaction of the entirety of the Accrued Salary for each of Mr.
Faulkner and Mr. Wajcenberg, the Company issued 1 share of Series D Preferred Stock to each of Charles Faulkner and Simon Wajcenberg.
9
Item 6. [Reserved]
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.